gastric damage ↑ nsaid costs
TRANSCRIPT
INTERNATIONAL RESEARCH & OPINION
Gastric damage i NSAID costs
For every $US 1 spent on using NSAIDs to treat elderly patients, an extra $US0.35 is spent treating the gastropathies associated with the use of these agents.
Researchers affiliated with Kaiser Pennanente Northwest Division in Oregon, US, reached this conclusion in a study which examined the direct and indirect costs of NSAID use during 1992 among members of the health maintenance organisation (HMO) who were aged> 65 years. The ambulatory healthcare and inpatient gastropathy costs of a 5% sample of HMO members who developed NSAID-related gastropathy in 1987 were used to estimate the total NSAID-associated gastropathy costs of the elderly NSAID users in 1992. All costs were defined from the perspective of the HMO.
Hospital costs total $US450 000 Just over 30% of 46822 elderly HMO members
were dispensed ~ 1 NSAID prescription during 1992. The total estimated cost of outpatient NSAID-associated gastropathies, including antiulcer treatment, among these patients was SUS 162 496. For the estimated 77 elderly HMO members hospitalised with an NSAIDassociated gastropathy in 1992, the total hospitalisation cost, with and without surgery, was estimated to be $US450 285. In the elderly HMO popUlation, the outpatient phannacy cost (acquisition and dispensing costs) for NSAIDs in 1992 totalled $US679 637. The estimated total cost* of treating NSAID-associated (J""trnn"thv in thp ""mp v""r U1"" ~T T~fi I? 7~ 1 O---C-- --- .1 --- --- ----- J-- .. - ..,. ----- . - --
• includes outpatient, inpatient, and drug acquisition and dispensing costs
Johnson RE. Hornbrook Me. Hooker RS, Woodson GT, Shneidman R. Analysis of the costs of NSAID-associated gastropathy: experience in a US Health Maintenance Organisation. PharmacoEconomics 12: 76-88. Jui 1997
~ Editorial comment: Preliminary findings of this study were reported in PharmacoEconomics & Outcomes News 81: 6,28 Sep 1996; 800469274.
1173-550319710121-()009I$Ol .00C AdlslnterNltioNlI Limited 1997. All rights reserved PharmacoEconomics & Ou1comes News 19 Jul 1997 No. 121
9